Quinn Grainne 4

4 · PERRIGO Co plc · Filed Mar 7, 2023

Form 4

Period: 2023-03-03

EVP, Chief Medical Officer

Transactions

Award
Ordinary Shares
2023-03-03$38.75/sh+5,419$209,986→ 14,537 total
Tax Payment
Ordinary Shares
2023-03-03$38.75/sh−2,818$109,198→ 11,719 total
Exercise/Conversion
Ordinary Shares
2023-03-03$38.75/sh+1,052$40,765→ 12,771 total
Tax Payment
Ordinary Shares
2023-03-03$38.75/sh−548$21,235→ 12,223 total
Exercise/Conversion
Ordinary Shares
2023-03-03$38.75/sh+1,584$61,380→ 13,807 total
Tax Payment
Ordinary Shares
2023-03-03$38.75/sh−824$31,930→ 12,983 total
Exercise/Conversion
Restricted Stock Units
2023-03-03−1,052→ 0 total
→ Ordinary Shares (1,052 underlying)
Exercise/Conversion
Restricted Stock Units
2023-03-03−1,584→ 1,583 total
→ Ordinary Shares (1,584 underlying)

Footnotes (6)

[F1]Vesting of performance-based restricted stock units granted on March 5, 2020.
[F2]Vesting of service-based restricted stock units granted on March 5, 2020.
[F3]Vesting of service-based restricted stock units granted on March 5, 2021.
[F4]Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.
[F5]Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2021.
[F6]Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022.

Documents

2 files